These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28809750)

  • 1. Need for better PTH assays for clinical research and patient treatment.
    Hocher B; Zeng S
    Clin Chem Lab Med; 2018 Jan; 56(2):183-185. PubMed ID: 28809750
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidation of PTH: in vivo feature or effect of preanalytical conditions?
    Ursem SR; Vervloet MG; Hillebrand JJG; de Jongh RT; Heijboer AC
    Clin Chem Lab Med; 2018 Jan; 56(2):249-255. PubMed ID: 28809747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary Hyperparathyroidism.
    Hocher B; Yin L
    Nephron; 2017; 136(2):137-142. PubMed ID: 28183082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations.
    Couchman L; Taylor DR; Krastins B; Lopez MF; Moniz CF
    Clin Chem Lab Med; 2014 Sep; 52(9):1251-63. PubMed ID: 24762644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease.
    Almond A; Ellis AR; Walker SW;
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):63-7. PubMed ID: 22096021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trueness, precision and stability of the LIAISON 1-84 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays.
    Valcour A; Zierold C; Blocki FA; Hawkins DM; Martin KJ; Rao SD; Bonelli F
    Clin Chem Lab Med; 2018 Aug; 56(9):1476-1482. PubMed ID: 29750642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
    Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
    Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone: new assays, new receptors.
    Martin KJ; Akhtar I; González EA
    Semin Nephrol; 2004 Jan; 24(1):3-9. PubMed ID: 14730504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
    Gao P; D'Amour P
    Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Garrett G; Sardiwal S; Lamb EJ; Goldsmith DJ
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):299-312. PubMed ID: 22403273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of assays for parathyroid hormone.
    Goodman WG
    Semin Dial; 2005; 18(4):296-301. PubMed ID: 16076352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Sprague SM; Moe SM
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):321. PubMed ID: 23160258
    [No Abstract]   [Full Text] [Related]  

  • 14. Parathyroid hormone measurement in CKD.
    Souberbielle JC; Roth H; Fouque DP
    Kidney Int; 2010 Jan; 77(2):93-100. PubMed ID: 19812537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
    Goodman WG
    Blood Purif; 2003; 21(1):118-23. PubMed ID: 12596757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K; Ong L; Sethi SK; Saw S
    Clin Biochem; 2013 Jun; 46(9):781-6. PubMed ID: 23384535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?
    Lau WL; Kalantar-Zadeh K; Kovesdy CP; Mehrotra R
    Hemodial Int; 2014 Oct; 18(4):720-4. PubMed ID: 25597344
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays.
    Brossard JH; Lepage R; Cardinal H; Roy L; Rousseau L; Dorais C; D'Amour P
    Clin Chem; 2000 May; 46(5):697-703. PubMed ID: 10794753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric immunoassay raises doubt for the existence of parathyroid hormone fragment 7-84.
    Singh RJ; Hines JM; Lopez MF; Krastins B; Hoofnagle AN
    Clin Chem; 2015 Mar; 61(3):558-60. PubMed ID: 25597752
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism.
    Meyer SK; Zorn M; Frank-Raue K; Büchler MW; Nawroth P; Weber T
    Eur J Endocrinol; 2009 Feb; 160(2):275-81. PubMed ID: 19004983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.